National Institute of Allergy and Infectious Diseases; Notice of Meeting, 50342 [2022-17612]
Download as PDF
<![CDATA[
50342
Federal Register / Vol. 87, No. 157 / Tuesday, August 16, 2022 / Notices
applicable, the business or professional
affiliation of the interested person.
Individuals will be able to view the
meeting via NIH Videocast. Select the
following link for Videocast access
instructions: https://www.nichd.nih.gov/
about/advisory/nachhd/Pages/virtualmeeting.aspx.
Information is also available on the
Institute’s/Center’s home page: https://
www.nichd.nih.gov/about/advisory/council,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: August 10, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–17561 Filed 8–15–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the AIDS Research Advisory
Committee, NIAID.
The meeting will be open to the
public. The open session will be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov).
Individuals who need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting.
Name of Committee: AIDS Research
Advisory Committee, NIAID.
Date: September 12, 2022.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: Report of Division Director and
Division Staff.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 8D49,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Pamela Gilden, Branch
Chief, Science Planning and Operations
Branch, Division of AIDS, National Institute
of Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room
8D49, Rockville, MD 20852–9831, 301–594–
9954, pamela.gilden@nih.gov.
Any interested person may file written
comments with the committee by forwarding
VerDate Sep<11>2014
18:35 Aug 15, 2022
Jkt 256001
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Contact: Lisa S. Davis, M.S., Social
Science Analyst, Center for Substance
Abuse Prevention, 5600 Fishers Lane,
Rockville, Maryland 20857, Telephone:
(240) 276–1440, Email: Lisa.Davis@
samhsa.hhs.gov.
Anastasia M. Donovan,
Public Health Advisor, Division of Workplace
Programs.
Dated: August 11, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–17610 Filed 8–15–22; 8:45 am]
[FR Doc. 2022–17612 Filed 8–15–22; 8:45 am]
DEPARTMENT OF HOMELAND
SECURITY
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Notice of Meeting
Pursuant to Public Law 92–463,
notice is hereby given that the
Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Center for Substance Abuse Prevention’s
(CSAP) Drug Testing Advisory Board
(DTAB) will convene via web
conference on September 20th, 2022,
from 10:00 a.m. EDT to 4:30 p.m. EDT.
The board will meet in closed-session
September 20th, 2022, from 10 a.m. EDT
to 4:30 p.m. EDT, to review and discuss
draft revisions to the proposed
Mandatory Guidelines for Federal
Workplace Drug Testing Programs (hair)
that have not been made public by the
Department of Health and Human
Services. Therefore, the September 20th,
2022 meeting, from 10 a.m. to 4:30 p.m.
EDT, is closed to the public, as
determined by the Assistant Secretary
for Mental Health and Substance Use,
SAMHSA, in accordance with 5 U.S.C.
552b(c)(9)(B) and 5 U.S.C. App. 2,
Section 10(d).
Meeting information and a roster of
DTAB members may be obtained by
accessing the SAMHSA Advisory
Committees website, https://
www.samhsa.gov/about-us/advisorycouncils/meetings or by contacting the
Designated Federal Officer, Lisa Davis.
Committee Name: Substance Abuse
and Mental Health Services
Administration, Center for Substance
Abuse Prevention, Drug Testing
Advisory Board.
Dates/Time/Type: September 20th,
2022, from 10 a.m. EDT to 4:30 p.m.
EDT: Closed.
Place: Substance Abuse and Mental
Health Services Administration, 5600
Fishers Lane, Rockville, MD 20857.
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
BILLING CODE 4162–20–P
Federal Emergency Management
Agency
[Internal Agency Docket No. FEMA–4584–
DR; Docket ID FEMA–2022–0001]
Washington; Amendment No. 4 to
Notice of a Major Disaster Declaration
Federal Emergency
Management Agency, DHS.
ACTION: Notice.
AGENCY:
This notice amends the notice
of a major disaster declaration for the
State of Washington (FEMA–4584–DR),
dated February 4, 2021, and related
determinations.
SUMMARY:
DATES:
This change occurred on July 8,
2022.
FOR FURTHER INFORMATION CONTACT:
Dean Webster, Office of Response and
Recovery, Federal Emergency
Management Agency, 500 C Street SW,
Washington, DC 20472, (202) 646–2833.
SUPPLEMENTARY INFORMATION: The
Federal Emergency Management Agency
(FEMA) hereby gives notice that
pursuant to the authority vested in the
Administrator, under Executive Order
12148, as amended, David R. Gervino, of
FEMA is appointed to act as the Federal
Coordinating Officer for this disaster.
This action terminates the
appointment of Toney L. Raines as
Federal Coordinating Officer for this
disaster.
The following Catalog of Federal
Domestic Assistance Numbers (CFDA)
are to be used for reporting and drawing
funds: 97.030, Community Disaster
Loans; 97.031, Cora Brown Fund;
97.032, Crisis Counseling; 97.033,
Disaster Legal Services; 97.034, Disaster
Unemployment Assistance (DUA);
97.046, Fire Management Assistance
Grant; 97.048, Disaster Housing
Assistance to Individuals and
Households In Presidentially Declared
Disaster Areas; 97.049, Presidentially
Declared Disaster Assistance—Disaster
Housing Operations for Individuals and
E:\FR\FM\16AUN1.SGM
16AUN1
]]>Agencies
[Federal Register Volume 87, Number 157 (Tuesday, August 16, 2022)]
[Notices]
[Page 50342]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-17612]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the AIDS Research
Advisory Committee, NIAID.
The meeting will be open to the public. The open session will be
videocast and can be accessed from the NIH Videocasting and Podcasting
website (https://videocast.nih.gov). Individuals who need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: AIDS Research Advisory Committee, NIAID.
Date: September 12, 2022.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: Report of Division Director and Division Staff.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 8D49,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Pamela Gilden, Branch Chief, Science Planning
and Operations Branch, Division of AIDS, National Institute of
Allergy and Infectious Diseases, National Institutes of Health, 5601
Fishers Lane, Room 8D49, Rockville, MD 20852-9831, 301-594-9954,
[email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: August 11, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-17612 Filed 8-15-22; 8:45 am]
BILLING CODE 4140-01-P
